WUHAN, Oct. 31 (Xinhua) — The branches of Chinese major telecom operators in central China’s Hubei Province announced Thursday the launch of commercial 5G applications in the province.
Wuhan City, the capital of Hubei, is expected to have 10,000 5G base stations by the end of 2019, said Song Qizhu, head of Hubei Provincial Communication Administration.
China Telecom has established a 5G network covering airports, railway stations and other areas in the city, which will also help boost the digital and intelligent transformation of the industries with 5G technologies, said Li Hongbo, general manager of the company’s Hubei branch.
China Mobile Hubei Branch has activated 1,580 5G base stations in the city as of mid-October, achieving the 5G coverage of universities, transportation hubs and other densely populated areas, according to the branch.
Over the past few days, the mainstream press has vigorously pushed back against a theory about the origins of the coronavirus that has now infected as many as 70,000+ people in Wuhan alone (depending on whom you believe). The theory is that China obtained the coronavirus via a Canadian research program, and started molding it into a bioweapon at the Institute of Virology in Wuhan. Politifact pointed the finger at Zero Hedge, in particular, though the story was widely shared across independent-leaning media.
The theory is that the virus, which was developed by infectious disease experts to function as a bio-weapon, originated in the Wuhan-based lab of Dr. Peng Zhou, China’s preeminent researcher of bat immune systems, specifically in how their immune systems adapt to the presence of viruses like coronavirus and other destructive viruses. Somehow, the virus escaped from the lab, and the Hunan fish market where the virus supposedly originated is merely a ruse.
Now, a respected epidemiologist who recently caught flack for claiming in a twitter threat that the virus appeared to be much more contagious than initially believed is pointing out irregularities in the virus’s genome that suggests it might have been genetically engineered for the purposes of a weapon, and not just any weapon but the deadliest one of all.
Summary: The smell of roses while learning and during sleep helps increase memory and learning skills. The study reports a significant increase in learning success by 30% if a person is exposed to the smell of roses during both learning and sleep phases. [40% if during learning, sleep and test phases -rw]
Source: University of Freiburg
Effortless learning during sleep is the dream of many people. The supportive effect of smells on learning success when presented both during learning and sleep was first proven in an extensive sleep laboratory study. Researchers at the University of Freiburg – Medical Center, the Freiburg Institute for Frontier Areas of Psychology and Mental Health (IGPP) and the Faculty of Biology at the University of Freiburg have now shown that this effect can be also achieved very easily outside the lab. For the study, pupils in two school classes learned English vocabulary – with and without scent sticks during the learning period and also at night. The students remembered the vocabulary much better with a scent. The study was published in the Nature Group’s Open Access journal Scientific Reports on 27 January 2020.
“We showed that the supportive effect of fragrances works very reliably in everyday life and can be used in a targeted way,” said study leader PD Dr. Jürgen Kornmeier, head of the Perception and Cognition Research Group at the Freiburg-based IGPP and scientist at the Department of Psychiatry and Psychotherapy at the University of Freiburg – Medical Center in Germany….
… In condition “N” none of the participants received any odor cue. In the condition “LT” the test participants were exposed to rose fragrance as odor cue during the vocabulary learning periods at home and during the vocabulary test at school, which took place one week after the initial presentation of the vocabulary unit by the teacher.
In the condition “LS” participants received the odor cue during the learning period at home as well as every night of the week before the test. At night, the odor cue was present during the whole duration of the sleeping period.
In the condition “LST” participants received the odor cue during the learning period at home, every night while sleeping at home and during the subsequent vocabulary test at school, seven days after the learning unit….
The FDA is complicit in turning another supplement into an expensive drug. Action Alert!
Earlier this year, the FDA fired off warning letters to seventeen companies that, in the agency’s view, were illegally marketing supplements to treat Alzheimer’s disease. One of the supplements targeted in the FDA’s action was piracetam, a derivative of GABA, continuing an FDA trend of attacking brain health supplements to protect drug industry profits.
Piracetam has been on the market as a supplement for years. It is approved as a drug in Europe and prescribed for cognitive impairment and dementia. Researchers think that piracetam helps the brain by boosting energy production in brain cells. As we age, our brain cells decline in their ability to generate energy; this decline in energy causes cellular “debris” to accumulate which can kill brain cells and eventually lead to senility.
The FDA’s treatment of piracetam highlights how broken our system is. This relates to the “new supplement” notification process we’ve discussed many times. Any supplement that came to the market after 1994 is considered a “new supplement.” Companies that want to sell new supplements must notify the FDA 75 days in advance of marketing the product. In implementing this provision of the law, though, the FDA has been trying to turn this notification process into a de facto pre-approval process. The agency has also adopted an expansive view of what constitutes a new supplement.
Additionally, if a compound is being investigated for use in a drug, and that process started before a “new supplement” notification was filed on that compound, then that substance cannot be sold as a supplement—even if the drug company abandons the research on that compound. This, remember, is what happened with pyridoxamine, a crucial form of vitamin B6. Additionally, L-glutamine and CBD have both been turned into drugs through this mechanism….
To doctors opening patients’ electronic records across the U.S., the alert would have looked innocuous enough.
A pop-up would appear, asking about a patient’s level of pain. Then, a drop-down menu would list treatments ranging from a referral to a pain specialist to a prescription for an opioid painkiller.
Click a button, and the program would create a treatment plan. From 2016 to spring 2019, the alert went off about 230 million times.
The tool existed thanks to a secret deal. Its maker, a software company called Practice Fusion, was paid by a major opioid manufacturer to design it in an effort to boost prescriptions for addictive pain pills — even though overdose deaths had almost tripled during the prior 15 years, creating a public-health disaster. The software was used by tens of thousands of doctors’ offices.
Its existence was revealed this week thanks to a government investigation. Practice Fusion agreed to pay $145 million to resolve civil and criminal cases, according to documents filed in a Vermont federal court. Practice Fusion admitted to the scheme with an unnamed opioid maker, though the details of the government case closely match a public research partnership between Practice Fusion and Purdue Pharma Inc., which makes OxyContin.
Representatives for Purdue Pharma and the Vermont U.S. attorney declined to comment. Health-software company Allscripts Healthcare Solutions Inc., which bought Practice Fusion for $100 million in 2018, said in a statement the conduct predated the deal and it has “further strengthened” compliance at Practice Fusion, but didn’t answer specific questions about the settlement….